P. Ron Ellis, President and CEO at ENDOCYTE INC (ECYT), sold 3,000 shares at $12.00 ($36K) on 2013-12-02, disclosed to the SEC on 2013-12-04.
Scheduled sale ($36k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ECYT | SELL | 2013-09-05 | $44K | — | Filing → |
| ECYT | SELL | 2013-08-06 | $54K | — | Filing → |
| ECYT | SELL | 2013-07-17 | $51K | — | Filing → |